SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals
2022 · Nature Communications · 156 citations
https://doi.org/10.1038/s41467-022-32389-8
K
Komal Srivastava
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
86
Papers
3.8K
Citations
23
h-index
38
i10-index
Komal Srivastava is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies & Immunotherapy and Immune Responses. The author has an h-index of 23, co-authored 74 publications.
Papers by this author
worksSARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase
2024 · Immunity · 119 citations
https://doi.org/10.1016/j.immuni.2024.01.017
Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients
2023 · Cell Reports Medicine · 49 citations
https://doi.org/10.1016/j.xcrm.2023.101079
IgM N-glycosylation correlates with COVID-19 severity and rate of complement deposition
2024 · Nature Communications · 23 citations
https://doi.org/10.1038/s41467-023-44211-0
Development of a novel serological assay for the detection of mpox infection in vaccinated populations
2023 · Journal of Medical Virology · 21 citations
https://doi.org/10.1002/jmv.29134
SARS-CoV-2 BA.1 and BA.2 breakthrough infections boost antibody responses to early Omicron subvariants but not BQ.1.1 or XBB.1.5
2024 · Cell Reports Medicine · 6 citations
https://doi.org/10.1016/j.xcrm.2024.101474
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat